| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
matrix metallopeptidase 1 | 0.385 | 0.885 | 7.7E-18 |
|
phenotype | 0.400 | None | 0.989 | 3 | 0 | 1993 | 2020 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
phenotype | 0.400 | None | 0.978 | 3 | 0 | 1992 | 2020 | ||||||||
|
integrin subunit beta 1 | 0.496 | 0.808 | 0.98 |
|
phenotype | 0.400 | None | 1.000 | 3 | 0 | 2003 | 2019 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
phenotype | 0.400 | None | 0.972 | 3 | 0 | 1995 | 2020 | ||||||||
|
caveolin 1 | 0.388 | 0.885 | 8.3E-03 |
|
phenotype | 0.400 | None | 0.990 | 3 | 0 | 2001 | 2019 | ||||||||
|
erb-b2 receptor tyrosine kinase 3 | 0.448 | 0.808 | 1.7E-15 |
|
phenotype | 0.400 | None | 0.969 | 3 | 0 | 1998 | 2019 | ||||||||
|
S100 calcium binding protein A4 | 0.448 | 0.769 | 6.2E-03 |
|
phenotype | 0.400 | None | 0.962 | 3 | 0 | 1992 | 2020 | ||||||||
|
mitogen-activated protein kinase 1 | 0.330 | 0.923 | 1.00 |
|
phenotype | 0.400 | None | 0.991 | 3 | 0 | 2003 | 2020 | ||||||||
|
mitogen-activated protein kinase 3 | 0.379 | 0.885 | 3.7E-02 |
|
phenotype | 0.400 | None | 1.000 | 3 | 0 | 1998 | 2020 | ||||||||
|
superoxide dismutase 2 | 0.379 | 0.923 | 0.15 |
|
phenotype | 0.400 | None | 1.000 | 2 | 0 | 1996 | 2019 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
phenotype | 0.400 | None | 0.996 | 2 | 0 | 2001 | 2020 | ||||||||
|
ETS variant transcription factor 4 | 0.545 | 0.500 | 2.9E-08 |
|
phenotype | 0.400 | None | 1.000 | 2 | 0 | 1995 | 2019 | ||||||||
|
snail family transcriptional repressor 1 | 0.474 | 0.808 | 0.22 |
|
phenotype | 0.400 | None | 1.000 | 2 | 0 | 2007 | 2020 | ||||||||
|
thymidine phosphorylase | 0.495 | 0.769 | 1.2E-04 |
|
phenotype | 0.400 | None | 0.960 | 2 | 0 | 1996 | 2019 | ||||||||
|
plasminogen activator, urokinase | 0.425 | 0.923 | 2.3E-06 |
|
phenotype | 0.400 | None | 0.981 | 2 | 0 | 1990 | 2019 | ||||||||
|
tissue factor pathway inhibitor 2 | 0.521 | 0.769 | 8.4E-04 |
|
phenotype | 0.400 | None | 1.000 | 2 | 0 | 2000 | 2019 | ||||||||
|
galectin 3 | 0.392 | 0.846 | 2.3E-05 |
|
phenotype | 0.400 | None | 0.986 | 2 | 0 | 1992 | 2020 | ||||||||
|
reversion inducing cysteine rich protein with kazal motifs | 0.547 | 0.731 | 1.9E-10 |
|
phenotype | 0.400 | None | 1.000 | 2 | 0 | 1998 | 2019 | ||||||||
|
Rac family small GTPase 1 | 0.429 | 0.962 | 0.76 |
|
phenotype | 0.400 | None | 0.985 | 1 | 0 | 2001 | 2020 | ||||||||
|
cytochrome P450 family 19 subfamily A member 1 | 0.410 | 0.885 | 1.7E-05 |
|
phenotype | 0.400 | None | 1.000 | 1 | 0 | 1999 | 2019 | ||||||||
|
transforming growth factor beta receptor 2 | 0.413 | 0.846 | 0.13 |
|
phenotype | 0.400 | None | 1.000 | 1 | 0 | 2001 | 2019 | ||||||||
|
ERCC excision repair 1, endonuclease non-catalytic subunit | 0.445 | 0.846 | 1.6E-07 |
|
phenotype | 0.400 | None | 0.917 | 1 | 0 | 2008 | 2019 | ||||||||
|
interleukin 18 | 0.365 | 0.923 | 3.1E-02 |
|
phenotype | 0.400 | None | 1.000 | 1 | 0 | 2003 | 2018 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
phenotype | 0.400 | None | 0.952 | 1 | 0 | 1991 | 2020 | ||||||||
|
N-myc downstream regulated 1 | 0.488 | 0.731 | 1.1E-02 |
|
phenotype | 0.400 | None | 1.000 | 1 | 0 | 2003 | 2020 |